Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 31:14:45.
doi: 10.4103/abr.abr_285_23. eCollection 2025.

Serum β-hCG, AMH, TSH, and PRL Levels in Predicting the Outcome of Early Pregnancy 14 Days after Embryo Transfer: A Prospective Cohort Study

Affiliations

Serum β-hCG, AMH, TSH, and PRL Levels in Predicting the Outcome of Early Pregnancy 14 Days after Embryo Transfer: A Prospective Cohort Study

Fatemeh Davari Tanha et al. Adv Biomed Res. .

Abstract

Background: Pregnancy outcomes in assisted reproductive technology (ART) are influenced by the ability of the embryos to create a pregnancy and maternal factors such as hormone levels to maintain and develop the pregnancy. This study investigated the role of β-human chorionic gonadotropin (β-hCG), anti-mullerian hormone (AMH), thyroid-stimulating hormone (TSH), and prolactin (PRL) in predicting pregnancy outcomes and determined cutoff values in women undergoing ARTs.

Materials and methods: This prospective study included 153 women who underwent infertility treatment in the Department of Reproductive Medicine of the Yas Hospital, Tehran University of Medical Sciences (Tehran, Iran). Serum β-hCG level on day 14 after embryo transfer and serum AMH, TSH, and PRL were measured. Patients with β-hCG levels >25 mIU/ml were included in the study. Finally, any statistically significant relationships between these serum values and clinical pregnancy and live birth rate were investigated. To predict pregnancy outcomes with β-hCG levels, a receiver operating characteristic curve was used to estimate the β-hCG cutoff values.

Results: Serum β-hCG levels were significantly higher in live-birth patients than in other patients. The β-hCG cutoff value for live births was 830 mIU/ml, with an AUC of 0.5920, sensitivity of 61.04%, and specificity of 56.58%. Serum AMH, TSH, and PRL levels did not show any significant results.

Conclusions: Serum β-hCG levels on day 14 after embryo transfer can be used to predict the probability of live birth in patients undergoing infertility treatment.

Keywords: Embryo transfer; human chorionic-gonadotropin; pregnancy outcomes.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Statistical comparison of β-HCG levels (a) in cases with and without clinical pregnancy, (b) in clinical pregnancy cases with and without live birth, and (c) in cases with and without live birth
Figure 2
Figure 2
Statistical comparison of (a) age, (b) AMH levels, (c) BMI, (d) prolactin levels, and (e) TSH levels in cases with and without live birth
Figure 3
Figure 3
Receiver operating characteristics (ROC) curve of β-hCG (a) in cases of clinical pregnancy with or without of live birth and (b) in cases with or without of live birth

Similar articles

References

    1. Mittal S, Gupta P, Malhotra N, Singh N. Serum estradiol as a predictor of success of in vitro fertilization. J Obstet Gynaecol India. 2014;64:124–9. - PMC - PubMed
    1. Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010;8:102. - PMC - PubMed
    1. Guo X, Wang F, Li J, Guo Z, Wang J. Prediction performance of serum placental growth factor (PLGF) human chorionic gonadotropin β (β-hCG) and PAPP-A levels in early pregnancy for pregnancy outcomes. Pak J Med Sci. 2022;38:1877–82. - PMC - PubMed
    1. Granger E, Tal R. Anti-Müllerian hormone and its predictive utility in assisted reproductive technologies outcomes. Clin Obstet Gynecol. 2019;62:238–56. - PubMed
    1. Iancu ME, Albu AI, Albu DN. Prolactin relationship with fertility and in vitro fertilization outcomes—A review of the literature. Pharmaceuticals. 2023;16:122. - PMC - PubMed

LinkOut - more resources